New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)

“This new partnership will enhance our current approaches and further distinguish ADMET Predictor as the preeminent property prediction platform in the drug discovery space”

Read More

PROJECT OPTIMUS WEBINAR

FDA will present and discuss Project Optimus, an initiative from the Oncology Center of Excellence (OCE) to reform the dose optimization and dose selection paradigm in oncology drug development.

Register Here

Employees Celebrate 25th Anniversary with St. Jude Children’s Hospital

Tenured employees support St. Jude in finding cures and saving children

Read More

GastroPlus® as an Educational Tool: Teaching of Pharmacokinetics and Biopharmaceutics through PBPK Modeling

Outcomes of the recent course implementation revealed that this approach increased student understanding of biopharmaceutics and pharmacokinetics.

Register Here

Sign up for our Monthly Newsletter

Receive the latest research in modeling and simulation software & solutions directly in your inbox.

Subscribe Here

Modeling & Simulation

To improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services.

Learn More

Pop PK/PD Data Analysis

Providing strategic pharmacology and pharmacometric consulting services, PK/PD model development with NONMEM, clinical trial simulations, exposure-response evaluations, dose justification strategies and related data management services.

Learn More

Pharma Safety & Efficacy

Ensuring the safety of drug therapies by leveraging our expertise in the areas of drug-induced liver injury, metabolic diseases, and modeling and simulation.

Learn More

POP Modeling & Simulation

Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticianby bringing breakthrough advances to the modeling & simulation community in user-friendly tools.

Learn More

We Improve Health Through Innovative Solutions

Model-Based Drug Development To Make Better Data-Driven Decisions

Our reputation as thought leaders in the areas of ADMET property prediction,  physiologically-based pharmacokinetics (PBPK) modeling, pharmacometrics, and quantitative systems pharmacology/toxicology is earned through the success our clients have found through their relationship with us. We have the talent and 20+ years experience to translate science into user-friendly software and provide expert consulting supporting drug discovery, clinical development research, and regulatory submissions.

Get started today!

Sign up for a FREE evaluation or
schedule a call with one of our consultants.

Questions? Email info@simulations-plus.com

Get started today!

Sign up for a FREE evaluation in 60 seconds or
schedule a call with one of our consultants.

Questions? Email info@simulations-plus.com

Get started today!

Sign up for a FREE evaluation in 60 seconds or
schedule a call with one of our consultants.

Questions? Email info@simulations-plus.com